SUBSTANCE-P AS NEUROGENIC MEDIATOR OF ANTIDROMIC VASODILATION AND NEUROGENIC PLASMA EXTRAVASATION
SUBSTANCE-P AS NEUROGENIC MEDIATOR OF ANTIDROMIC VASODILATION AND NEUROGENIC PLASMA EXTRAVASATION
复制标题
DOI:
10.1007/bf00500282
复制
发表时间:
1979-01-01
影响因子:
3.6
通讯作者:
HOLZER, P
中科院分区:
文献类型:
--
作者:
LEMBECK, F;HOLZER, P
Antidromic vasodilation and neurogenic plasma extravasation were induced by antidromic stimulation of the saphenous nerve in guanethidine-treated rats. Vasodilation was measured by the change of outflow from the femoral vein and plasma extravasation was determined by Evans blue exudation. Antidromic vasodilation was reduced by 85% in adult rats which were pretreated with capsaicin on the 2nd day of life. Antidromic vasodilation was inhibited by 46% after pretreatment with cimetidine plus mepyramine and by 64% after pretreatment with compound 48/80 [p-methoxyphenethyl methyl amine-formaldehyde product], but was not affected by pretreatment with cimetidine, atropine, methysergide or indomethacin. Neurogenic plasma extravasation was reduced by 50% after pretreatment with cimetidine plus mepyramine, and by 88% after pretreatment with compound 48/80, but was not altered after pretreatment with indomethacin. Infusion of substance P into the femoral artery dose-dependently produced vasodilation (threshold: 0.1 pmol/min-) and plasma extravasation (threshold: 0.5 pmol/min). Vasodilation induced by substance P was inhibited by 47% after pretreatment with cimetidine plus mepyramine and by 58% after pretreatment with compound 48/80. Plasma extravasation induced by substance P was reduced by 61% after pretreatment with cimetidine plus mepyramine and by 81% after pretreatment with compound 48/80. Pretreatment with indomethacin had no influence on substance P-induced vasodilation and plasma extravasation. Apparently vasodilation and plasma extravasation after antidromic stimulation of sensory nerves are initiated by peripheral release of substance P from chemosensitive pain fibers. The actions of substance P include, besides direct effects, release of histamine from mast cells.